Taking cholesterol drugs called evolocumab or alirocumab doesn’t seem to raise your risk of bleeding in the brain — the numbers show it’s about the same as not taking them.

38

Pro

0

Against

Evidence from Studies

Supporting (1)

38

Community contributions welcome

38

Primary and secondary prevention of stroke and cardiovascular events using evolocumab and alirocumab: Meta-analysis of randomized controlled trials.

Systematic Review With Meta-Analysis

Human

2024 Jun

The study looked at whether two cholesterol drugs (evolocumab and alirocumab) increase the risk of bleeding in the brain, and found no significant increase — just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Primary and secondary prevention of stroke and cardiovascular events using evolocumab and alirocumab: Meta-analysis of randomized controlled trials.

Score: 38

DOI: 10.5414/CP204506

Similar Assertions

Taking certain cholesterol drugs called evolocumab or alirocumab might lower the chance of having a stroke, whether you've already had heart problems or not.

38

0

85%

For people with clogged arteries who are already taking cholesterol drugs, adding a medicine called evolocumab can help lower their chance of having a stroke.

74

0

77%

Taking a drug called evolocumab can lower the chance of having a first major heart problem by 25% in people at high risk who’ve never had a heart attack or stroke before.

100

80

76%

For people with hardened arteries who are on cholesterol-lowering drugs, adding a drug called evolocumab doesn’t seem to raise their risk of bleeding in the brain.

74

0

75%

Taking a cholesterol drug called evolocumab to get really low LDL levels doesn’t seem to cause serious side effects like memory problems, diabetes, cataracts, or brain bleeds over 3 years, according to a major study.

1

0

74%